PPAR-α ligands as potential therapeutic agents for wet age-related macular degeneration

Research output: Contribution to journalArticle

Abstract

The peroxisome proliferator-activated receptors (PPAR's) are members of the steroid/thyroid nuclear receptor, superfamily of transcription factors. There are currently three known PPAR subtypes, α, β, and γ. The PPARs are now recognized participants in a number of biological pathways some of which are implicated in the pathogenesis of age-related macular degeneration (AMD). These include immune modulation, lipid regulation, and oxidant/antioxidant pathways important to the onset and progression of "dry" AMD, and vascular endothelial growth factor (VEGF) mediated pathways that stimulate choroidal neovascularization (CNV), characteristic of "wet" AMD. PPAR- α is found in retina and also on vascular cells important to formation of CNV. At this time, however, relatively little is known about potential contributions of PPAR- α to the pathogenesis of dry and wet AMD. This review examines current literature for potential roles of PPAR- α in the pathogenesis and potential treatment of AMD with emphasis on prevention and treatment of wet AMD.

Original languageEnglish (US)
Article number821592
JournalPPAR Research
DOIs
StatePublished - 2008

Fingerprint

Peroxisome Proliferator-Activated Receptors
Macular Degeneration
Ligands
Choroidal Neovascularization
Therapeutics
Cytoplasmic and Nuclear Receptors
Oxidants
Vascular Endothelial Growth Factor A
Blood Vessels
Retina
Thyroid Gland
Transcription Factors
Antioxidants
Steroids
Lipids

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Drug Discovery

Cite this

@article{146a14a722744ed3a9817f0ec3ec1076,
title = "PPAR-α ligands as potential therapeutic agents for wet age-related macular degeneration",
abstract = "The peroxisome proliferator-activated receptors (PPAR's) are members of the steroid/thyroid nuclear receptor, superfamily of transcription factors. There are currently three known PPAR subtypes, α, β, and γ. The PPARs are now recognized participants in a number of biological pathways some of which are implicated in the pathogenesis of age-related macular degeneration (AMD). These include immune modulation, lipid regulation, and oxidant/antioxidant pathways important to the onset and progression of {"}dry{"} AMD, and vascular endothelial growth factor (VEGF) mediated pathways that stimulate choroidal neovascularization (CNV), characteristic of {"}wet{"} AMD. PPAR- α is found in retina and also on vascular cells important to formation of CNV. At this time, however, relatively little is known about potential contributions of PPAR- α to the pathogenesis of dry and wet AMD. This review examines current literature for potential roles of PPAR- α in the pathogenesis and potential treatment of AMD with emphasis on prevention and treatment of wet AMD.",
author = "Peter Gehlbach and Marisol Cano",
year = "2008",
doi = "10.1155/2008/821592",
language = "English (US)",
journal = "PPAR Research",
issn = "1687-4757",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - PPAR-α ligands as potential therapeutic agents for wet age-related macular degeneration

AU - Gehlbach, Peter

AU - Cano, Marisol

PY - 2008

Y1 - 2008

N2 - The peroxisome proliferator-activated receptors (PPAR's) are members of the steroid/thyroid nuclear receptor, superfamily of transcription factors. There are currently three known PPAR subtypes, α, β, and γ. The PPARs are now recognized participants in a number of biological pathways some of which are implicated in the pathogenesis of age-related macular degeneration (AMD). These include immune modulation, lipid regulation, and oxidant/antioxidant pathways important to the onset and progression of "dry" AMD, and vascular endothelial growth factor (VEGF) mediated pathways that stimulate choroidal neovascularization (CNV), characteristic of "wet" AMD. PPAR- α is found in retina and also on vascular cells important to formation of CNV. At this time, however, relatively little is known about potential contributions of PPAR- α to the pathogenesis of dry and wet AMD. This review examines current literature for potential roles of PPAR- α in the pathogenesis and potential treatment of AMD with emphasis on prevention and treatment of wet AMD.

AB - The peroxisome proliferator-activated receptors (PPAR's) are members of the steroid/thyroid nuclear receptor, superfamily of transcription factors. There are currently three known PPAR subtypes, α, β, and γ. The PPARs are now recognized participants in a number of biological pathways some of which are implicated in the pathogenesis of age-related macular degeneration (AMD). These include immune modulation, lipid regulation, and oxidant/antioxidant pathways important to the onset and progression of "dry" AMD, and vascular endothelial growth factor (VEGF) mediated pathways that stimulate choroidal neovascularization (CNV), characteristic of "wet" AMD. PPAR- α is found in retina and also on vascular cells important to formation of CNV. At this time, however, relatively little is known about potential contributions of PPAR- α to the pathogenesis of dry and wet AMD. This review examines current literature for potential roles of PPAR- α in the pathogenesis and potential treatment of AMD with emphasis on prevention and treatment of wet AMD.

UR - http://www.scopus.com/inward/record.url?scp=43949121929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43949121929&partnerID=8YFLogxK

U2 - 10.1155/2008/821592

DO - 10.1155/2008/821592

M3 - Article

C2 - 18401454

AN - SCOPUS:43949121929

JO - PPAR Research

JF - PPAR Research

SN - 1687-4757

M1 - 821592

ER -